Jupiter Research Capital (Asia) Ltd’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.34M Buy
+72,402
New +$7.79M 0.92% 21
2026
Q2
– Sell
-11,954
Closed -$482K – 799
2026
Q1
$482K Buy
+11,954
New +$447K 0.05% 408

Other funds holding CORT

Jupiter Research Capital (Asia) Ltd's CORT Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 72,402 shares worth $8.34M. The stake represents 0.92% of the portfolio and ranks #21 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in CORT as recently as Q1 2026.

Jupiter Research Capital (Asia) Ltd first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. 463 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 72,402 shares of Corcept Therapeutics worth $8.34M as of Q3 2026.
  • Corcept Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Corcept Therapeutics made up 0.92% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #21 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 463 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.